“Can We Declare Victory and Move On?” The Case Against Funding Burden-of-Disease Studies

8Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Resources devoted to the development of burden-of-disease studies detract from much needed cost-effectiveness and cost-benefit studies. Practitioners need to help funders of burden-of-disease projects recognize the potential of all tools of decision analysis and economic evaluation in improving the efficiency and equity for the health care system.

Cite

CITATION STYLE

APA

Kymes, S. (2014, November 26). “Can We Declare Victory and Move On?” The Case Against Funding Burden-of-Disease Studies. PharmacoEconomics. Springer International Publishing. https://doi.org/10.1007/s40273-014-0200-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free